Oral bretylium tosylate use during pregnancy and subsequent breastfeeding: a case report.
A 39-year-old woman with long QT interval syndrome received chronic oral bretylium tosylate during pregnancy and subsequent breastfeeding. The pregnancy and delivery were uncomplicated and no side effects have been observed in the infant.
Gutgesell
M
M
Children's Medical Center, University of Virginia, Charlottesville 22908.
Overholt
E
E
Boyle
R
R
D000284:Administration, Oral; D000328:Adult; D001949:Bretylium Compounds / Q000009:adverse effects*; D001950:Bretylium Tosylate / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D007774:Lactation / Q000187:drug effects*; D008133:Long QT Syndrome / Q000188:drug therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy
D001949:Bretylium Compounds; D001950:Bretylium Tosylate